Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Sevoflurane on Oxygenation During One-Lung Ventilation
NCT05907525Completed
- Sponsor
- Pusan National University Hospital
- Start
- Jun 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of remimazolam (2 arms), sponsored by Pusan National University Hospital. Primary endpoint: Arterial Partial Pressure of Oxygen. Started Jun 2023; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05907525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05907525.